Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis

about

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis

Item

http://www.wikidata.org/entity/Q36195470

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pathologic Stage of Nonsmall C ...... Did Not Predict the Prognosis

@ast

Pathologic Stage of Nonsmall C ...... Did Not Predict the Prognosis

@en

type

Item

label

Pathologic Stage of Nonsmall C ...... Did Not Predict the Prognosis

@ast

Pathologic Stage of Nonsmall C ...... Did Not Predict the Prognosis

@en

prefLabel

Pathologic Stage of Nonsmall C ...... Did Not Predict the Prognosis

@ast

Pathologic Stage of Nonsmall C ...... Did Not Predict the Prognosis

@en

P1476

Pathologic Stage of Nonsmall C ...... Did Not Predict the Prognosis

@en

P2093

Cheng-Ta Yang

http://www.w3.org/2001/XMLSchema#string

Ching-Feng Wu

http://www.w3.org/2001/XMLSchema#string

Ching-Yang Wu

http://www.w3.org/2001/XMLSchema#string

Jui-Ying Fu

http://www.w3.org/2001/XMLSchema#string

Ming-Ju Hsieh

http://www.w3.org/2001/XMLSchema#string

Yi-Cheng Wu

http://www.w3.org/2001/XMLSchema#string

Ying-Huang Tsai

http://www.w3.org/2001/XMLSchema#string

Yun-Hen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data

Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial

Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.

Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial

A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer.

The new lung cancer staging system.

Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials.

[Non small cell lung cancer - comparison between clinical and pathological staging]

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.

P304

e1700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000001700

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283115549

http://www.w3.org/2001/XMLSchema#string

P698

26448022

http://www.w3.org/2001/XMLSchema#string

P932

4616767

http://www.w3.org/2001/XMLSchema#string